Castlight Health Announces Fourth Quarter and Full Year 2015 Results

Go back to Castlight Health Announces Fourth Quarter and Full Year 2015 Results

Castlight Health's (CSLT) Slight Beat and Mixed Guide Keeps Leerink Partners on the Sidelines - PT to $3.50

February 18, 2016 8:26 AM EST

Leerink Partners reiterated a Market Perform rating on Castlight Health Inc. (NYSE: CSLT), and cut the price target to $3.50 (from $5.00), following the company's 4Q earnings report. Revenue of $21.3m was slightly above guidance of $20.7-21m and consensus at $20.9m. Non-GAAP EPS came in at... More

Castlight Health (CSLT) Tops Q4 EPS by 1c

February 17, 2016 4:15 PM EST

Castlight Health (NYSE: CSLT) reported Q4 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $21.3 million versus the consensus estimate of $20.89 million.

GUIDANCE:

Castlight Health sees Q1 2016 EPS of ($0.16)-($0.15), versus the consensus of ($0.14).... More